Caspase-1 activation and proinflammatory cytokine release preceded the alteration of AD pathology and cognitive impairment, which might suggest that NLRP3 activation occurred in the early stage of AD (Tarkowski et al., 2003; de Calignon et al., 2010). The gene discussed is NLRP3; the disease is Cognitive impairment.